Merck gets US FDA nod of adult pneumococcal 15-valent conjugate vaccine
VAXNEUVANCE demonstrated non-inferior immune responses for the serotypes shared with PCV13 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
India tops in number of unvaccinated, under-vaccinated kids worldwide: UNICEF
It also noted that over three million of “zero-dose children” in 2020 lived in India
Lonza extends collaboration with biopharma client for antibody drug conjugate supply
Lonza did not name the client with whom it extended the agreement
Celltrion’s monoclonal antibody treatment for COVID-19 works against Delta variant: Study
Regdanvimab (CT-P59) also retained its neutralisation potency against the Lambda variant (C.37, first identified in Peru) using a…
Heat-tolerant COVID-19 vaccine from IISc effective against all major SARS-CoV-2 variants: Study
The research, published in the ACS Infectious Diseases journal on Thursday, showed that vaccine formulations by IISc-incubated…
Ocugen seeks approval for Covaxin in Canada
The move follows the release by Bharat Biotech of Phase 3 clinical trial results, which demonstrated efficacy and safety in nearly…
AI, big data will continue to disrupt pharma sector, say healthcare industry professionals in…
The COVID-19 pandemic has given businesses an unprecedented opportunity to implement technology-fueled changes to the way they…
RBI bulletin calls for diversification of pharma raw material imports, increasing pharma R&D…
Apart from securing own supply chain, the country can also use the pandemic to elevate the sector's position in the global supply…
Trial reveals BPaL regimen for highly drug-resistant TB is effective even with reduced dose of…
This regimen reduces the treatment time for highly drug-resistant forms of TB from 18 months or longer to a six-month duration
AccelTRA® Component program: Ensuring Quality, Speed and Simplicity in Generics Pharma Packaging
15th July 2021 | 3:00 PM - 4:30 PM IST | Live Webinar